BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 1901926)

  • 1. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition.
    Sanders PW; Herrera GA; Kirk KA; Old CW; Galla JH
    Lab Invest; 1991 Apr; 64(4):527-37. PubMed ID: 1901926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of myeloma cast nephropathy, light chain deposition disease, and nonamyloid fibrils in a patient with multiple myeloma.
    Qian Q; Leung N; Theis JD; Dogan A; Sethi S
    Am J Kidney Dis; 2010 Nov; 56(5):971-6. PubMed ID: 20870327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural immunolabeling in the diagnosis of monoclonal light-and heavy-chain-related renal diseases.
    Herrera GA; Turbat-Herrera EA
    Ultrastruct Pathol; 2010 May; 34(3):161-73. PubMed ID: 20455664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
    Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light chain nephropathy: histological and clinical aspects in 15 cases.
    Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
    Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
    Noel LH; Droz D; Ganeval D; Grunfeld JP
    Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy.
    Gu X; Barrios R; Cartwright J; Font RL; Truong L; Herrera GA
    Hum Pathol; 2003 Mar; 34(3):270-7. PubMed ID: 12673562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG heavy-chain deposition disease.
    Katz A; Zent R; Bargman JM
    Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraproteinemic renal diseases that involve the tubulo-interstitium.
    Herrera GA; Sanders PW
    Contrib Nephrol; 2007; 153():105-15. PubMed ID: 17075226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
    Iványi B
    Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Light-chain nephropathy].
    Iványi B; Nagy J; Varga G; Búzás E
    Orv Hetil; 1990 Aug; 131(33):1791-5. PubMed ID: 2119026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P; Plaisier E; Mougenot B; Aucouturier P
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic heterogeneity of renal light-chain deposition disease.
    Gokden N; Barlogie B; Liapis H
    Ultrastruct Pathol; 2008; 32(1):17-24. PubMed ID: 18300034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
    Herrera GA
    Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
    Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
    Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic manifestations of combined light-chain deposition disease and light-chain cast nephropathy.
    Gokden N; Cetin N; Colakoglu N; Kumar J; Abul-Ezz S; Barlogie B; Liapis H; Walker PD
    Ultrastruct Pathol; 2007; 31(2):141-9. PubMed ID: 17613994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal immunoglobin deposition disease, heavy chain deposition type.
    Fogo AB; Rossini M
    Am J Kidney Dis; 2003 Dec; 42(6):A48, E1-2. PubMed ID: 14655222
    [No Abstract]   [Full Text] [Related]  

  • 19. Proximal tubulopathies associated with monoclonal light chains: the spectrum of clinicopathologic manifestations and molecular pathogenesis.
    Herrera GA
    Arch Pathol Lab Med; 2014 Oct; 138(10):1365-80. PubMed ID: 25268200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.
    Gallo GR; Feiner HD; Katz LA; Feldman GM; Correa EB; Chuba JV; Buxbaum JN
    Am J Pathol; 1980 Jun; 99(3):621-44. PubMed ID: 6770693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.